If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 3 of 3
Low Dose Naltrexone in the Treatment of Central Neuropathic Pain After Traumatic Spinal Cord Injury: A Pilot Study
Objective
Treating Central Neuropathic Pain With Low Dose Naltrexone for Spinal Cord Injury
Protocol No
PMR-IIT-CUI-LDN
Multicenter, Double-blind, Randomized, Placebo Controlled, Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301), in Patients With Severe Traumatic Brain Injury (TBI).
Objective
Study to Assess the Safety of Amantadine Hydrochloride IV Solution in Patients With Severe TBI
Protocol No
NEURO-SHINKEI-TBI
Traumatic Incomplete Tetraplegia without Instability: A Prospective Multicenter Feasibility Study of Outcomes and Prognosis
Objective
Traumatic Incomplete Tetraplegia without Instability
Protocol No
NSUR-AOSPINE-IN-TWIN